Evolent announces Dr. Von Nguyen as incoming Chief Medical Officer, effective January 1
Evolent Health (NYSE: EVH) has announced the appointment of Dr. Von Nguyen as Chief Medical Officer, effective January 1, 2025. Dr. Nguyen, who joined Evolent as Chief Clinical Officer in July 2024, brings experience from Google's population health division, Blue Cross North Carolina, CDC, and CMS. He will succeed Dr. Andrew Hertler, who will transition to a part-time role as senior advisor and CMO emeritus after more than a decade with the company.
Dr. Nguyen's background includes roles in patient care, health policy, and clinical innovation. He previously helped design value-based programs in specialty and primary care at CMS and has worked in clinics serving underserved communities. Dr. Hertler, a medical oncologist with over 40 years of experience, will continue to focus on advancing innovation for Evolent's oncology management solution.
Evolent Health (NYSE: EVH) ha annunciato la nomina del Dr. Von Nguyen come Chief Medical Officer, a partire dal 1 gennaio 2025. Il Dr. Nguyen, che è entrato in Evolent come Chief Clinical Officer nel luglio 2024, porta con sé esperienza dal settore della salute della popolazione di Google, da Blue Cross North Carolina, CDC e CMS. Sostituirà il Dr. Andrew Hertler, che passerà a un ruolo part-time come senior advisor e CMO emerito dopo oltre un decennio in azienda.
Il background del Dr. Nguyen include ruoli nella cura dei pazienti, nella politica sanitaria e nell'innovazione clinica. In precedenza ha contribuito a progettare programmi basati sul valore nella medicina specialistica e primaria al CMS e ha lavorato in cliniche che servono comunità svantaggiate. Il Dr. Hertler, un oncologo medico con oltre 40 anni di esperienza, continuerà a concentrarsi sull'avanzamento dell'innovazione per la soluzione di gestione dell'oncologia di Evolent.
Evolent Health (NYSE: EVH) ha anunciado el nombramiento del Dr. Von Nguyen como Director Médico, con efecto a partir del 1 de enero de 2025. El Dr. Nguyen, quien se unió a Evolent como Director Clínico en julio de 2024, aporta experiencia de la división de salud poblacional de Google, Blue Cross North Carolina, CDC y CMS. Sucederá al Dr. Andrew Hertler, quien cambiará a un rol a tiempo parcial como asesor senior y CMO emérito después de más de una década en la empresa.
La trayectoria del Dr. Nguyen incluye roles en el cuidado de pacientes, política de salud e innovación clínica. Anteriormente ayudó a diseñar programas basados en el valor en la atención primaria y especializada en CMS y ha trabajado en clínicas que atienden a comunidades desatendidas. El Dr. Hertler, un oncólogo médico con más de 40 años de experiencia, continuará enfocándose en avanzar en la innovación para la solución de gestión de oncología de Evolent.
에볼렌트 헬스 (NYSE: EVH)는 Dr. 본 응우옌을 2025년 1월 1일부터 최고 의학 책임자로 임명했다고 발표했습니다. 응우옌 박사는 2024년 7월 에볼렌트의 최고 임상 책임자로 합류했으며, 구글의 인구 건강 부문, 블루 크로스 노스캐롤라이나, CDC 및 CMS에서의 경험을 가지고 있습니다. 그는 10년 이상 회사에서 활동한 Dr. 앤드류 헤르틀러를 대신하게 되며, 헤르틀러 박사는 선임 고문 및 명예 최고 의학 책임자로서 파트타임 역할로 전환합니다.
응우옌 박사의 배경은 환자 치료, 건강 정책, 그리고 임상 혁신에서의 역할을 포함합니다. 그는 이전에 CMS에서 전문 및 일차 진료의 가치 기반 프로그램을 설계하는 데 도움을 주었으며, 소외된 지역 사회를 위한 클리닉에서 근무한 경험이 있습니다. 40년 이상의 경험을 가진 의학 종양 전문의인 헤르틀러 박사는 앞으로도 에볼렌트의 종양 관리 솔루션을 위한 혁신을 발전시키는 데 집중할 것입니다.
Evolent Health (NYSE: EVH) a annoncé la nomination de Dr. Von Nguyen en tant que directeur médical, à compter du 1er janvier 2025. Dr. Nguyen, qui a rejoint Evolent en tant que directeur clinique en juillet 2024, apporte une expérience du secteur de la santé de la population de Google, de Blue Cross North Carolina, du CDC et du CMS. Il succédera à Dr. Andrew Hertler, qui passera à un rôle à temps partiel en tant qu'adviseur senior et CMO émérite après plus d'une décennie au sein de l'entreprise.
Le parcours du Dr. Nguyen inclut des rôles dans les soins aux patients, la politique de santé et l'innovation clinique. Auparavant, il a contribué à la conception de programmes basés sur la valeur dans les soins spécialisés et primaires au CMS et a travaillé dans des cliniques servant des communautés défavorisées. Le Dr. Hertler, oncologue médical avec plus de 40 ans d'expérience, continuera à se concentrer sur l'avancement de l'innovation pour la solution de gestion oncologique d'Evolent.
Evolent Health (NYSE: EVH) hat die Ernennung von Dr. Von Nguyen zum Chief Medical Officer bekanntgegeben, die am 1. Januar 2025 wirksam wird. Dr. Nguyen, der im Juli 2024 als Chief Clinical Officer zu Evolent kam, bringt Erfahrung aus der Bevölkerungsgesundheitsabteilung von Google, Blue Cross North Carolina, CDC und CMS mit. Er wird Dr. Andrew Hertler nachfolgen, der nach mehr als einem Jahrzehnt im Unternehmen in eine Teilzeitrolle als Senior Advisor und CMO Emeritus wechseln wird.
Der Hintergrund von Dr. Nguyen umfasst Rollen in der Patientenversorgung, Gesundheitspolitik und klinischer Innovation. Zuvor half er, wertbasierte Programme in der Spezial- und Primärversorgung bei CMS zu entwerfen, und hat in Kliniken gearbeitet, die unterversorgte Gemeinschaften bedienen. Dr. Hertler, ein medizinischer Onkologe mit über 40 Jahren Erfahrung, wird weiterhin den Fokus auf die Förderung von Innovationen für die Onkologie-Management-Lösung von Evolent legen.
- Appointment of experienced healthcare executive Dr. Von Nguyen with significant background in population health and value-based care
- Retention of former CMO Dr. Hertler in advisory capacity maintaining continuity in oncology management
- None.
Longtime CMO Dr. Andrew Hertler to serve as senior advisor and CMO emeritus.
Dr. Nguyen joined Evolent as Chief Clinical Officer in July 2024 after serving as clinical lead for population health at Google. Among other previous roles, he has been Chief Medical Officer at Blue Cross North Carolina, Deputy Associate Director of Policy and Strategy at the Centers for Disease Control and Prevention, and Senior Advisor at the Centers for Medicare and Medicaid Services, where he helped design value-based programs in specialty and primary care. Trained as a primary care physician, he has worked at clinics for underserved communities in the
"Dr. Nguyen's unique mix of experiences in delivering patient care, shaping health policy and powering clinical innovation at scale position him well to lead Evolent's own clinical quality programs," said Evolent President Dan McCarthy. "As he has already demonstrated in his short time here, Von's background and skills, combined with his profound empathy for patients and his relentless passion for bringing fresh solutions to status quo challenges, will accelerate our efforts to create a higher-quality, more affordable and less fragmented healthcare system."
Dr. Nguyen will succeed Dr. Andrew Hertler, who will move to a part-time role as senior advisor and CMO emeritus after more than a decade at Evolent. Dr. Hertler, a medical oncologist with more than 40 years in the field, will focus on advancing innovation for Evolent's oncology management solution.
"Dr. Hertler is a giant in the field of value-based specialty care and improving patient outcomes, and I am honored to succeed him," said Dr. Nguyen. "I came to Evolent to help accelerate our mission of making care simpler, higher quality, more affordable and more connected for patients dealing with complex health conditions. Our team of over 1,500 doctors, nurses and allied clinicians wake up every day focused on this mission, and I look forward to working with them in my new role to build on Dr. Hertler's strong legacy in the future."
About Evolent
Evolent (NYSE: EVH) specializes in better health outcomes for people with complex conditions through proven solutions that make healthcare simpler and more affordable. Evolent serves a national base of leading payers and providers and is consistently recognized as a top place to work in healthcare nationally. Learn more about how Evolent is changing the way healthcare is delivered by visiting evolent.com.
Contacts
Media: Jamie Manfuso, media@evolent.com
Investors: Seth R. Frank, sfrank@evolent.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/evolent-announces-dr-von-nguyen-as-incoming-chief-medical-officer-effective-january-1-302335408.html
SOURCE Evolent Health, Inc.
FAQ
When will Dr. Von Nguyen become CMO of Evolent Health (EVH)?
What was Dr. Von Nguyen's role before joining Evolent Health (EVH)?
What will be Dr. Andrew Hertler's new role at Evolent Health (EVH)?
How long has Dr. Andrew Hertler been with Evolent Health (EVH)?
